NIKA PHARMACEUTICALS, INC (NIKA) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$297.6K | -34.5% |
| 2024 | -$221.2K | -169.3% |
| 2023 | -$82.1K | -374.4% |
| 2022 | -$17.3K | +26.7% |
| 2021 | -$23.6K | -165.2% |
| 2020 | -$8.9K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$297.6K | -34.5% |
| 2024 | -$221.2K | -169.3% |
| 2023 | -$82.1K | -374.4% |
| 2022 | -$17.3K | +26.7% |
| 2021 | -$23.6K | -165.2% |
| 2020 | -$8.9K | — |